UNIVERSITY OF ALABAMA AT BIRMINGHAM
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury is a funding opportunity from UNIVERSITY OF ALABAMA AT BIRMINGHAM, up to 147015, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Arsenicals such as lewisite, diethylchloroarsine, diphenylchlorarsine, and diphenylcyanoarsine are extremely toxic chemicals that have been used in chemical warfare since World War I and continue to remain a threat to humans, who may be exposed through accidental or intentional mass population exposure. Topical…